Developing vaccines and antibodies for dangerous RNA viruses
Official title: Paramyxoviridae and Bunyavirales Vaccines and Antibodies Center (PABVAX)
Funded at University of Texas Med Br Galveston · NIH-10862496 · Data updated 2026-11-12
This study is working on new vaccines and treatments to help protect people from serious illnesses caused by certain viruses, aiming to improve prevention and care for those affected by these infections.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Med Br Galveston NIH-funded |
| Lab location | 1 site (Galveston, United States) |
| Project start | July 30, 2024 |
| Project end | June 30, 2027 |
| Funding year | 2024 |
| Award (this year) | $46,404,982 |
| NIH project number | 1U19AI181930-01 |
| Project ID | NIH-10862496 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit include individuals at risk of exposure to these high-priority viral pathogens, such as healthcare workers and those living in endemic regions.
✕Less likely to help
Patients with viral infections not related to the targeted pathogens may not receive any benefit from this research.
What this research studies
This research focuses on creating vaccines and therapeutic antibodies to combat emerging and reemerging RNA viruses that pose significant threats to public health. It specifically targets viruses from the Paramyxoviridae and Bunyavirales families, which are known to cause severe diseases such as hemorrhagic fevers. The approach involves studying these viruses and their interactions with the immune system to develop effective countermeasures. Patients may benefit from advancements in prevention and treatment options for these viral infections.
Why it matters
Potential benefit: If successful, this research could lead to effective vaccines and treatments for severe viral infections that currently have no approved therapies.
How similar studies have gone: Previous research has shown promise in developing vaccines and therapies for similar viral pathogens, indicating a potential for success in this area.
Where this research is happening
-
University of Texas Med Br Galveston
Galveston, United States Active
Researchers
- Principal investigator: Geisbert, Thomas William — University of Texas Med Br Galveston
- Study coordinator: Geisbert, Thomas William
Related research
Other NIH-funded projects on the same topics.
-
HPV and pregnancy risk: a big study following 1,280 pregnancies
A large pregnancy study at UTMB looks at whether human papillomavirus (HPV) during pregnancy is linked to problems like preterm birth.
-
West African Center for Emerging Infectious Diseases
A national West African collaboration is studying how dangerous viruses spread between animals and people, with the goal of improving prevention and response.
-
West African Center for Emerging Infectious Diseases
A multi-country program in West Africa aims to better understand how emerging infectious diseases spread from animals to people and how to prevent outbreaks that could affect the U.S.
-
West Africa Center for Emerging Infectious Diseases
A patient-facing center in West Africa studies how emerging viruses spread to people and livestock so we can better protect communities and prevent outbreaks.
-
West African Center for Emerging Infectious Diseases
Aiming to understand and prevent emerging viruses in West Africa to protect people in the U.S. and globally.
-
West Africa Center for Emerging Infectious Diseases
A US-funded center in West Africa aims to better understand and prevent outbreaks of deadly viruses by studying how diseases spread between animals, people, and the environment.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.